Home » Newsletters » BioWorld Science

BioWorld Science

July 14, 2022

View Archived Issues

FVIII-QQ gene transfer therapy shows advantage for treating hemophilia A

Novel genetic polymorphism associated with macroangiopathy risk

UCB SA patents DRD1 PAMs

Merck & Co. discloses new DNA polymerase inhibitors

Pfizer synthesizes IL-2 production inhibitors

Janssen Pharmaceutica identifies new Mcl-1 inhibitors

GLS1 inhibitor with antitumor activity in HCT116 xenograft model

Heptares Therapeutics divulges new histamine H4 receptor antagonists

Inflammation, coagulation and endothelial activation markers linked to HIV-associated TTP

A new series of broad-spectrum bacterial type II topoisomerase inhibitors: synthesis and evaluation

New salicylic acid derivatives act as double GO/LACH inhibitors to decrease oxalate production

SNP rs11549465 in HIF1A gene predicts glucocorticoid sensitivity in patients with ITP

FDA awards orphan drug designation to AVR-RD-05 for Hunter's syndrome

CytomX restructures and outlines plans for preclinical pipeline

KDM4B enzyme inhibitor tested for aggressive rhabdomyosarcoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...